-
Cowen Analysts Happy About Relypsa-Veltassa Launch, Say These Four Things Are Coming
Tuesday, January 26, 2016 - 10:31am | 381Read More...The share price of Relypsa Inc (NASDAQ: RLYP) has declined 32.09 percent over the past one month, following a 42.17 percent appreciation over the past three months. Cowen’s Eric Schmidt has maintained an Outperform rating on the company. Data from the drug-drug interaction study for...
-
Illumina Shares Lower Amid Action From Multiple Sell-Side Analysts
Thursday, January 7, 2016 - 4:44pm | 309Read More...Amid action from multiple sell-side analysts, shares of Illumina, Inc. (NASDAQ: ILMN) are trending downward on the day. Illumina was recently seen trading down 5.33 percent at $168.10 from a Wednesday close around $177. Thus far into Thursday's trading, the company's shares reached a high of 173.75...
-
Cowen Upgrades Coach, Says Improved Marketing And Promos Are Driving Traffic
Tuesday, December 15, 2015 - 10:38am | 320Read More...Coach Inc (NYSE: COH) shares have appreciated 7.3 percent over the past three months, after having fallen close to their 52-week low on September 28. Cowen’s Oliver Chen has upgraded the rating on the company from Market Perform to Outperform, while raising the price target from $35 to...
-
Cowen Downgrades Chipotle As 'Q4 Sales Were Far More Impacted From E. Coli Outbreak'
Monday, December 7, 2015 - 9:20am | 396Read More...Shares of Chipotle Mexican Grill, Inc. (NYSE: CMG) have declined 22.05 percent over the past three months, hitting a low of $536.19 on November 20. Andrew M. Charles of Cowen and Company has downgraded the rating on the company from Outperform to Market Perform, while lowering the price target...
-
Cowen Boosts Yum Brands; Taco Bell Growth, Buyback Potential Excite
Tuesday, December 1, 2015 - 10:33am | 269Read More...Shares of Yum! Brands, Inc. (NYSE: YUM) have dipped 19.52 percent over the past six months, declining almost to its 52-week low on November 12. Andrew M. Charles of Cowen and Company has upgraded the rating on the company from Market Perform to Outperform, while raising the price target from...
-
Genomic Health: A Prostate Play Helping Investors Get Ahead Of The Curve?
Thursday, November 19, 2015 - 2:31pm | 344Read More...The share price of Genomic Health, Inc. (NASDAQ: GHDX) has appreciated 36.28 percent over the past month, from $21.42 on October 20. Cowen and Company’s Doug Schenkel upgraded the rating on the company from Market Perform to Outperform, while raising the price target from $27 to $35....
-
Cowen Cuts GoPro Rating, Sees Uncertain Growth
Thursday, October 29, 2015 - 10:44am | 290Read More...The share price of GoPro Inc (NASDAQ: GPRO) has declined 61.14 percent year-to-date, touching a low of $27.60 on October 8. Robert W. Stone of Cowen and Company has downgraded the rating on the company from Outperform to Market Perform, while lowering the price target from $60 to $24....
-
Cowen Calls Fitbit's Outlook 'Conservative' Because Of This
Wednesday, October 28, 2015 - 10:03am | 306Read More...Fitbit Inc (NYSE: FIT) shares have appreciated 26.82 percent over the past six months, from a low of $29.68 on June 18. Cowen’s John Kernan has maintained a Market Perform rating on the company, while raising the price target from $38 to $41. Kernan believes that the Q3 consensus...
-
Apple's Q4 Has Upside, Field Triangulation Shows
Monday, October 26, 2015 - 8:47am | 287Read More...Apple Inc. (NASDAQ: AAPL) shares have risen 7.24 percent over the past five trading days, reaching a high of $119.122 on October 23. Cowen’s Timothy Arcuri has maintained a Market Perform rating on the company, while raising the price target from $130 to $135. Arcuri mentioned that...
-
Pfizer Upgraded At Cowen On 'Compelling' Valuation, Innovation
Tuesday, October 20, 2015 - 9:55am | 299Read More...Pfizer, Inc. (NYSE: PFE) shares are up 10.26 percent year to date, from $31.15 on December 31, 2014. Cowen’s Steve Scala has upgraded the rating on the company from Market Perform to Outperform, while raising the price target from $35 to $43. Scala believes that the stock is “...
-
Why Cowen Thinks Allergan Has Massive Upside To $400
Tuesday, September 29, 2015 - 10:29am | 265Read More...The share price of Allergan PLC (NYSE: AGN) has declined 17.25 percent over the past month, after having reached a high of $308.995 on August 31. Cowen’s Ken Cacciatore has maintained an Outpeform rating on the company, with a price target of $400. The company has provided its H2:15...
-
Cowen Is Upgrading Spirit Airlines; Will It Lift Investors' Spirits, Too?
Friday, September 25, 2015 - 3:16pm | 318Read More...Cowen and Company upgraded Spirit Airlines Incorporated (NASDAQ: SAVE) from Market Perform to Outperform on Friday. The firm established a price target of $60.00. Shares of Spirit Airlines are up more than 2.5 percent on Friday trading. In a report issued Friday, Cowen and Company analysts...
-
'Attractive Entry Points' In WebMD And Everyday Health Following Clinton's Sell-Off Plan
Wednesday, September 23, 2015 - 1:29pm | 485Read More...Cowen believes that the selloff in WebMD Health Corp. (NASDAQ: WBMD) and Everyday Health Inc (NYSE: EVDY) following Hillary Clinton’s drug pricing plan is overdone. If implemented, the plan could serve to reduce the advertising budgets of many pharma companies. Cowen’s long-term...
-
Why This Cowen Analyst Sees 60% Upside In Glu Mobile
Wednesday, September 23, 2015 - 10:56am | 355Read More...The share price of Glu Mobile Inc. (NASDAQ: GLUU) has risen by almost 20 percent year-to-date. Cowen’s Doug Creutz has maintained an Outperform rating and price target of $8 on the company. The initial performance of Deer Hunter 2016 appears promising, while Kim Kardashian:...
-
How GoPro Gets To $60
Wednesday, September 23, 2015 - 10:37am | 356Read More...GoPro Inc (NASDAQ: GPRO) shares have lost 50 percent year-to-date, and are trading close to the lower end of their 52-week range of $30.55 - $98.47 Cowen and Company’s Robert W. Stone maintained an Outperform rating for the company, while reducing the price target from $76 to $60....
